Drug Candidate Name
Drug Candidate Description

Lorem ipsum

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Company Name
Company Information
GET IN TOUCH

Lorem ipsum

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Drug Candidates
Therapeutic AreaPsychiatry/Psychology
IndicationDown syndrome
Development Phase
Precl
Ph 1
Ph 2
Ph 3
Breakthrough
Orphan Drug
Therapeutic AreaRare Diseases
IndicationFragile X syndrome
Development Phase
Precl
Ph 1
Ph 2
Ph 3
Breakthrough
Orphan Drug
Drug Class
Cell therapiesNeuroprotectantsSmall moleculesAntidementiasAntiparkinsoniansAntipsychoticsAnxiolyticsBehavioural disorder therapiesMood stabilisers
Mechanism of Action
Central nervous system modulators, Nervous system modulators, Dopaminergic cell replacements, Signal transduction pathway stimulants, Cell transdifferentiation inhibitors, Hippo signaling pathway modulators
New Molecular Entity
Shelved
Attachments and Links
Non-Confidential Information
Drug candidate and company presentations; links to publications, clinical trials, press releases, videos and medias